BCL2 and neoplasm: Venetoclax is a first-in-class pro-apoptotic BCL-2 Homology-3 (BH3) mimetic that selectively antagonizes the anti-apoptotic BCL-2 protein, thereby rapidly inducing apoptosis in sensitive tumor cells.